Arteriosclerosis and Thrombosis, Vol 11, 1237-1244, Copyright © 1991 by American Heart Association

ARTICLES

Apolipoprotein E polymorphisms affect atherosclerosis in young males. Pathobiological Determinants of Atherosclerosis in Youth (PDAY) Research Group

JE Hixson
Southwest Foundation for Biomedical Research, San Antonio, TX 78228- 0147.

Investigators in eight communities collected aortas, right coronary arteries, blood and liver samples, and associated information from 720 young males, aged 15-34 years, who died of external causes. Genotypes for apolipoprotein (apo) E isoforms (E2, E3, and E4) were determined from hepatic DNA by restriction isotyping (restriction enzyme isoform genotyping) of amplified apo E sequences. Pathologists graded the arteries for atherosclerotic lesions, and a central laboratory measured lipoprotein cholesterol concentrations. Allele frequencies were different between blacks and whites (p less than 0.0001). E2 and E4 frequencies were higher and E3 frequency was lower in blacks than in whites. Among the common genotypes in both whites and blacks, E2E3 heterozygotes had the lowest levels of total serum cholesterol and low density lipoproteins, E3E4 had the highest levels, and E3E3 had intermediate levels. Apo E genotypes differed in mean percent surface area involvement with lesions in the thoracic aorta and the abdominal aorta of both whites and blacks (p less than or equal to 0.0002). Among the common genotypes, E2E3 heterozygotes had the least involvement of both thoracic and abdominal aortas with lesions, E3E4 had the greatest involvement (with the exception of the thoracic aorta in whites), and E3E3 had intermediate involvement. Apo E genotype accounted for 5.7% in whites and 5.9% in blacks of the observed variation in lesions for the thoracic aorta, and for 5.9% in whites and 7.0% in blacks for the abdominal aorta. Adjusting for cholesterol levels did not change apo E genotypic effects appreciably, an observation suggesting that genotypic effects on arterial lesions may not be mediated entirely by changes in serum cholesterol concentrations.

This article has been cited by other articles:

				G. D. KOLOVOU, K. K. ANAGNOSTOPOULOU, P. KOSTAKOU, V. GIANNAKOPOULOU, C. MIHAS, G. HATZIGEORGIOU, I. K. VASILIADIS, D. P. MIKHAILIDIS, and D. V. COKKINOS Apolipoprotein E Gene Polymorphism and Obesity Status in Middle-aged Men with Coronary Heart Disease In Vivo, January 1, 2009; 23(1): 33 - 39. [Abstract] [Full Text] [PDF]

				L. E. Viiri, K. M. Viiri, E. Ilveskoski, H. Huhtala, M. Maki, P. J. Tienari, M. Perola, T. Lehtimaki, and P. J. Karhunen Interactions of Functional Apolipoprotein E Gene Promoter Polymorphisms With Smoking on Aortic Atherosclerosis Circ Cardiovasc Genet, December 1, 2008; 1(2): 107 - 116. [Abstract] [Full Text] [PDF]

				S. Cosentino, N. Scarmeas, E. Helzner, M. M. Glymour, J. Brandt, M. Albert, D. Blacker, and Y. Stern APOE {varepsilon}4 allele predicts faster cognitive decline in mild Alzheimer disease Neurology, May 6, 2008; 70(19_Part_2): 1842 - 1849. [Abstract] [Full Text] [PDF]

				G. Liew, A. Shankar, J. J. Wang, R. Klein, M. S. Bray, D. J. Couper, A. R. Sharrett, and T. Y. Wong Apolipoprotein E Gene Polymorphisms and Retinal Vascular Signs: The Atherosclerosis Risk in Communities (ARIC) Study Arch Ophthalmol, June 1, 2007; 125(6): 813 - 818. [Abstract] [Full Text] [PDF]

				C Smith, D I Graham, L S Murray, J Stewart, and J A R Nicoll Association of APOE e4 and cerebrovascular pathology in traumatic brain injury. J. Neurol. Neurosurg. Psychiatry, March 1, 2006; 77(3): 363 - 366. [Abstract] [Full Text] [PDF]

				N Scarmeas, C G Habeck, J Hilton, K E Anderson, J Flynn, A Park, and Y Stern APOE related alterations in cerebral activation even at college age J. Neurol. Neurosurg. Psychiatry, October 1, 2005; 76(10): 1440 - 1444. [Abstract] [Full Text] [PDF]

				A. Scuteri, S. S. Najjar, D. Muller, R. Andres, C. H. Morrell, A. B. Zonderman, and E. G. Lakatta apoE4 allele and the natural history of cardiovascular risk factors Am J Physiol Endocrinol Metab, August 1, 2005; 289(2): E322 - E327. [Abstract] [Full Text] [PDF]

				B. Keavney, A. Palmer, S. Parish, S. Clark, L. Youngman, J. Danesh, C. McKenzie, M. Delepine, M. Lathrop, R. Peto, et al. Lipid-related genes and myocardial infarction in 4685 cases and 3460 controls: discrepancies between genotype, blood lipid concentrations, and coronary disease risk Int. J. Epidemiol., October 1, 2004; 33(5): 1002 - 1013. [Abstract] [Full Text] [PDF]

				N. Scarmeas, G. M. Hadjigeorgiou, A. Papadimitriou, B. Dubois, M. Sarazin, J. Brandt, M. Albert, K. Marder, K. Bell, L. S. Honig, et al. Motor signs during the course of Alzheimer disease Neurology, September 28, 2004; 63(6): 975 - 982. [Abstract] [Full Text] [PDF]

				G. B. MacKensen, M. Swaminathan, L. K. Ti, H. P. Grocott, B. G. Phillips-Bute, J. P. Mathew, M. F. Newman, C. A. Milano, and M. Stafford-Smith Preliminary report on the interaction of apolipoprotein E polymorphism with aortic atherosclerosis and acute nephropathy after CABG Ann. Thorac. Surg., August 1, 2004; 78(2): 520 - 526. [Abstract] [Full Text] [PDF]

				C Infante-Rivard, E Levy, G-E Rivard, M Guiguet, and J-C Feoli-Fonseca Small babies receive the cardiovascular protective apolipoprotein {varepsilon}2 allele less frequently than expected J. Med. Genet., August 1, 2003; 40(8): 626 - 629. [Full Text]

				G. Kolovou, D. Daskalova, and D. P. Mikhailidis Apolipoprotein E Polymorphism and Atherosclerosis Angiology, January 1, 2003; 54(1): 59 - 71. [Abstract] [PDF]

				T. Lehtimaki, P. Dastidar, H. Jokela, T. Koivula, S. Lehtinen, C. Ehnholm, and R. Punnonen Effect of Long-Term Hormone Replacement Therapy on Atherosclerosis Progression in Postmenopausal Women Relates to Functional Apolipoprotein E Genotype J. Clin. Endocrinol. Metab., September 1, 2002; 87(9): 4147 - 4153. [Abstract] [Full Text] [PDF]

				R. S. Wilson, J. A. Schneider, L. L. Barnes, L. A. Beckett, N. T. Aggarwal, E. J. Cochran, E. Berry-Kravis, J. Bach, J. H. Fox, D. A. Evans, et al. The Apolipoprotein E {epsilon}4 Allele and Decline in Different Cognitive Systems During a 6-Year Period Arch Neurol, July 1, 2002; 59(7): 1154 - 1160. [Abstract] [Full Text] [PDF]

				L. Djousse, R. H. Myers, M. A. Province, S. C. Hunt, J. H. Eckfeldt, G. Evans, J. M. Peacock, and R. C. Ellison Influence of Apolipoprotein E, Smoking, and Alcohol Intake on Carotid Atherosclerosis: National Heart, Lung, and Blood Institute Family Heart Study Stroke, May 1, 2002; 33(5): 1357 - 1361. [Abstract] [Full Text] [PDF]

				M. A. Austin Ethical Issues in Human Genome Epidemiology: A Case Study Based on The Japanese American Family Study in Seattle, Washington Am. J. Epidemiol., April 1, 2002; 155(7): 585 - 592. [Abstract] [Full Text] [PDF]

				J. E. Eichner, S. T. Dunn, G. Perveen, D. M. Thompson, K. E. Stewart, and B. C. Stroehla Apolipoprotein E Polymorphism and Cardiovascular Disease: A HuGE Review Am. J. Epidemiol., March 15, 2002; 155(6): 487 - 495. [Abstract] [Full Text] [PDF]

				A.J.C. Slooter, M. L. Bots, L. M. Havekes, A. I. del Sol, M. Cruts, D. E. Grobbee, A. Hofman, C. Van Broeckhoven, J.C.M. Witteman, and C. M. van Duijn Apolipoprotein E and Carotid Artery Atherosclerosis: The Rotterdam Study Stroke, September 1, 2001; 32(9): 1947 - 1952. [Abstract] [Full Text] [PDF]

				M. F. Newman, D. T. Laskowitz, W. D. White, J. L. Kirchner, H. P. Grocott, M. Stafford-Smith, M. H. Sketch, R. H. Jones, J. G. Reves, and A. M. Saunders Apolipoprotein E Polymorphisms and Age at First Coronary Artery Bypass Graft Anesth. Analg., April 1, 2001; 92(4): 824 - 829. [Abstract] [Full Text] [PDF]

				H. C McGill Jr, C A. McMahan, E. E Herderick, G. T Malcom, R. E Tracy, and J. P Strong Origin of atherosclerosis in childhood and adolescence Am. J. Clinical Nutrition, November 1, 2000; 72 (5): 1307S - 1315S. [Abstract] [Full Text] [PDF]

				C. R. Isasi, S. Shea, R. J. Deckelbaum, S. C. Couch, T. J. Starc, J. D. Otvos, and L. Berglund Apolipoprotein epsilon 2 Allele Is Associated With an Anti-atherogenic Lipoprotein Profile in Children: The Columbia University BioMarkers Study Pediatrics, September 1, 2000; 106(3): 568 - 575. [Abstract] [Full Text]

				M. F. Newman, T. O. Stanley, and H. P. Grocott Strategies to Protect the Brain During Cardiac Surgery Seminars in Cardiothoracic and Vascular Anesthesia, July 1, 2000; 4(2): 53 - 64. [Abstract] [PDF]

				N. Hirono, M. Yasuda, S. Tanimukai, H. Kitagaki, and E. Mori Effect of the Apolipoprotein E {epsilon}4 Allele on White Matter Hyperintensities in Dementia Stroke, June 1, 2000; 31(6): 1263 - 1268. [Abstract] [Full Text] [PDF]

				Y. Kokubo, A. H. Chowdhury, C. Date, T. Yokoyama, H. Sobue, and H. Tanaka Age-Dependent Association of Apolipoprotein E Genotypes With Stroke Subtypes in a Japanese Rural Population Stroke, June 1, 2000; 31(6): 1299 - 1306. [Abstract] [Full Text] [PDF]

				L. U. Gerdes, C. Gerdes, K. Kervinen, M. Savolainen, I. C. Klausen, P. S. Hansen, Y. A. Kesaniemi, and O. Fargeman The Apolipoprotein {epsilon}4 Allele Determines Prognosis and the Effect on Prognosis of Simvastatin in Survivors of Myocardial Infarction : A Substudy of the Scandinavian Simvastatin Survival Study Circulation, March 28, 2000; 101(12): 1366 - 1371. [Abstract] [Full Text] [PDF]

				L. Zhu, L. Fratiglioni, Z. Guo, H. Basun, E. H. Corder, B. Winblad, and M. Viitanen Incidence of Dementia in Relation to Stroke and the Apolipoprotein E {epsilon}4 Allele in the Very Old : Findings From a Population-Based Longitudinal Study Stroke, January 1, 2000; 31(1): 53 - 60. [Abstract] [Full Text] [PDF]

				A. J. C. Slooter, M. Cruts, A. Ott, M. L. Bots, J. C. M. Witteman, A. Hofman, C. Van Broeckhoven, M. M. B. Breteler, and C. M. van Duijn The effect of APOE on dementia is not through atherosclerosis: The Rotterdam Study Neurology, October 22, 1999; 53(7): 1593 - 1593. [Abstract] [Full Text]

				S. Cheng, M. A. Grow, C. Pallaud, W. Klitz, H. A. Erlich, S. Visvikis, J. J. Chen, C. R. Pullinger, M. J. Malloy, G. Siest, et al. A Multilocus Genotyping Assay for Candidate Markers of Cardiovascular Disease Risk Genome Res., October 1, 1999; 9(10): 936 - 949. [Abstract] [Full Text]

				M. O. McCarron, D. Delong, and M. J. Alberts APOE genotype as a risk factor for ischemic cerebrovascular disease: A meta-analysis Neurology, October 1, 1999; 53(6): 1308 - 1308. [Abstract] [Full Text]

				E. Ilveskoski, M. Perola, T. Lehtimaki, P. Laippala, V. Savolainen, J. Pajarinen, A. Penttila, K. H. Lalu, A. Mannikko, K. K. Liesto, et al. Age-Dependent Association of Apolipoprotein E Genotype With Coronary and Aortic Atherosclerosis in Middle-Aged Men : An Autopsy Study Circulation, August 10, 1999; 100(6): 608 - 613. [Abstract] [Full Text] [PDF]

				M. Orth, W. Weng, H. Funke, A. Steinmetz, G. Assmann, M. Nauck, J. Dierkes, A. Ambrosch, K. H. Weisgraber, R. W. Mahley, et al. Effects of a Frequent Apolipoprotein E Isoform, ApoE4Freiburg (Leu28->Pro), on Lipoproteins and the Prevalence of Coronary Artery Disease in Whites Arterioscler. Thromb. Vasc. Biol., May 1, 1999; 19(5): 1306 - 1315. [Abstract] [Full Text] [PDF]

				C. Merchant, M.-X. Tang, S. Albert, J. Manly, Y. Stern, and R. Mayeux The influence of smoking on the risk of Alzheimer's disease Neurology, April 1, 1999; 52(7): 1408 - 1408. [Abstract] [Full Text] [PDF]

				M. F. Newman, D. T. Laskowitz, A. M. Saunders, A. M. Grigore, and H. P. Grocott Genetic Predictors of Perioperative Neurologic and Neuropsychological Injury and Recovery Seminars in Cardiothoracic and Vascular Anesthesia, March 1, 1999; 3(1): 34 - 46. [Abstract] [PDF]

				S. L. R. Kardia, M. B. Haviland, R. E. Ferrell, and C. F. Sing The Relationship Between Risk Factor Levels and Presence of Coronary Artery Calcification is Dependent on Apolipoprotein E Genotype Arterioscler. Thromb. Vasc. Biol., February 1, 1999; 19(2): 427 - 435. [Abstract] [Full Text] [PDF]

				R. W. Wissler and J. P. Strong Risk Factors and Progression of Atherosclerosis in Youth Am. J. Pathol., October 1, 1998; 153(4): 1023 - 1033. [Full Text] [PDF]

				Y. Huang, X. Q. Liu, S. C. Rall Jr., and R. W. Mahley Apolipoprotein E2 Reduces the Low Density Lipoprotein Level in Transgenic Mice by Impairing Lipoprotein Lipase-mediated Lipolysis of Triglyceride-rich Lipoproteins J. Biol. Chem., July 10, 1998; 273(28): 17483 - 17490. [Abstract] [Full Text] [PDF]

				M. Margaglione, D. Seripa, C. Gravina, E. Grandone, G. Vecchione, G. Cappucci, G. Merla, S. Papa, A. Postiglione, G. Di Minno, et al. Prevalence of Apolipoprotein E Alleles in Healthy Subjects and Survivors of Ischemic Stroke : An Italian Case-Control Study Stroke, February 1, 1998; 29(2): 399 - 403. [Abstract] [Full Text] [PDF]

				L. Ferrucci, J. M. Guralnik, M. Pahor, T. Harris, M.-C. Corti, M.-C. MHS, B. T. Hyman, R. B. Wallace, and R. J. Havlik Apolipoprotein E {epsilon}2 Allele and Risk of Stroke in the Older Population Stroke, December 1, 1997; 28(12): 2410 - 2416. [Abstract] [Full Text]

				C. Kessler, C. Spitzer, D. Stauske, S. Mende, J. Stadlmuller, R. Walther, and R. Rettig The Apolipoprotein E and ß-Fibrinogen G/A-455 Gene Polymorphisms Are Associated With Ischemic Stroke Involving Large-Vessel Disease Arterioscler. Thromb. Vasc. Biol., November 1, 1997; 17(11): 2880 - 2884. [Abstract] [Full Text]

				M. Lefevre, H. N. Ginsberg, P. M. Kris-Etherton, P. J. Elmer, P. W. Stewart, A. Ershow, T. A. Pearson, P. S. Roheim, R. Ramakrishnan, J. Derr, et al. ApoE Genotype Does Not Predict Lipid Response to Changes in Dietary Saturated Fatty Acids in a Heterogeneous Normolipidemic Population Arterioscler. Thromb. Vasc. Biol., November 1, 1997; 17(11): 2914 - 2923. [Abstract] [Full Text]

				L. Cattin, M. Fisicaro, M. Tonizzo, M. Valenti, G.M. Danek, M. Fonda, P.G. Da Col, S. Casagrande, E. Pincetti, M. Bovenzi, et al. Polymorphism of the Apolipoprotein E Gene and Early Carotid Atherosclerosis Defined by Ultrasonography in Asymptomatic Adults Arterioscler. Thromb. Vasc. Biol., January 1, 1997; 17(1): 91 - 94. [Abstract] [Full Text]

				P. W.F. Wilson, E. J. Schaefer, M. G. Larson, and J. M. Ordovas Apolipoprotein E Alleles and Risk of Coronary Disease: A Meta-analysis Arterioscler. Thromb. Vasc. Biol., October 1, 1996; 16(10): 1250 - 1255. [Abstract] [Full Text]

				J. G. Terry, G. Howard, M. Mercuri, M. G. Bond, and J. R. Crouse III Apolipoprotein E Polymorphism Is Associated With Segment-Specific Extracranial Carotid Artery Intima-Media Thickening Stroke, October 1, 1996; 27(10): 1755 - 1759. [Abstract] [Full Text]

				S. Tonstad, O. Joakimsen, E. Stensland-Bugge, T. P. Leren, L. Ose, D. Russell, and K. H. Bonaa Risk Factors Related to Carotid Intima-Media Thickness and Plaque in Children With Familial Hypercholesterolemia and Control Subjects Arterioscler. Thromb. Vasc. Biol., August 1, 1996; 16(8): 984 - 991. [Abstract] [Full Text]

				H. Basun, E.H. Corder, Z. Guo, L. Lannfelt, L.S. Corder, K.G. Manton, B. Winblad, and M. Viitanen Apolipoprotein E Polymorphism and Stroke in a Population Sample Aged 75 Years or More Stroke, August 1, 1996; 27(8): 1310 - 1315. [Abstract] [Full Text]

				Y. Nakata, T. Katsuya, H. Rakugi, S. Takami, M. Ohishi, K. Kamino, J. Higaki, Y. Tabuchi, Y. Kumahara, T. Miki, et al. Polymorphism of the Apolipoprotein E and Angiotensin-Converting Enzyme Genes in Japanese Subjects With Silent Myocardial Ischemia Hypertension, June 1, 1996; 27(6): 1205 - 1209. [Abstract] [Full Text]

				J. Kuusisto, L. Mykkanen, K. Kervinen, Y. A. Kesaniemi, and M. Laakso Apolipoprotein E4 Phenotype Is Not an Important Risk Factor for Coronary Heart Disease or Stroke in Elderly Subjects Arterioscler. Thromb. Vasc. Biol., September 1, 1995; 15(9): 1280 - 1286. [Abstract] [Full Text]

				X. L. Wang, R. M. McCredie, and D. E. L. Wilcken Polymorphisms of the Apolipoprotein E Gene and Severity of Coronary Artery Disease Defined by Angiography Arterioscler. Thromb. Vasc. Biol., August 1, 1995; 15(8): 1030 - 1034. [Abstract] [Full Text]

				O. Kosunen, S. Talasniemi, M. Lehtovirta, O. Heinonen, S. Helisalmi, A. Mannermaa, L. Paljarvi, M. Ryynanen, P.J. Riekkinen Sr, and H. Soininen Relation of Coronary Atherosclerosis and Apolipoprotein E Genotypes in Alzheimer Patients Stroke, May 1, 1995; 26(5): 743 - 748. [Abstract] [Full Text]

				M. Dammerman and J. L. Breslow Genetic Basis of Lipoprotein Disorders Circulation, January 15, 1995; 91(2): 505 - 512. [Full Text]

				D. M. Dreon, H. A. Fernstrom, B. Miller, and R. M. Krauss Apolipoprotein E Isoform Phenotype and LDL Subclass Response to a Reduced-Fat Diet Arterioscler. Thromb. Vasc. Biol., January 1, 1995; 15(1): 105 - 111. [Abstract] [Full Text]

				P. W. F. Wilson, R. H. Myers, M. G. Larson, J. M. Ordovas, P. A. Wolf, and E. J. Schaefer Apolipoprotein E Alleles, Dyslipidemia, and Coronary Heart Disease: The Framingham Offspring Study JAMA, December 7, 1994; 272(21): 1666 - 1671. [Abstract] [PDF]

				M N Payne, A F Jones, R G Murray, and J M Beattie Atherosclerotic disease and cognitive decline BMJ, August 6, 1994; 309(6951): 411a - 411. [Full Text]